ID   5NTC_RAT                Reviewed;         560 AA.
AC   D3ZMY7;
DT   23-FEB-2022, integrated into UniProtKB/Swiss-Prot.
DT   23-FEB-2022, sequence version 4.
DT   02-OCT-2024, entry version 90.
DE   RecName: Full=Cytosolic purine 5'-nucleotidase {ECO:0000305|PubMed:6260203};
DE            EC=3.1.3.5 {ECO:0000269|PubMed:6260203};
DE            EC=3.1.3.99 {ECO:0000269|PubMed:6260203};
DE   AltName: Full=Cytosolic nucleoside phosphotransferase 5'N {ECO:0000250|UniProtKB:P49902};
DE            EC=2.7.1.77 {ECO:0000250|UniProtKB:P49902};
GN   Name=Nt5c2 {ECO:0000312|RGD:2323387};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   IDENTIFICATION, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, SUBSTRATE
RP   SPECIFICITY, ACTIVITY REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=6260203; DOI=10.1016/0005-2744(81)90326-0;
RA   Itoh R.;
RT   "Purification and some properties of cytosol 5'-nucleotidase from rat
RT   liver.";
RL   Biochim. Biophys. Acta 657:402-410(1981).
CC   -!- FUNCTION: Broad specificity cytosolic 5'-nucleotidase that catalyzes
CC       the dephosphorylation of 6-hydroxypurine nucleoside 5'-monophosphates
CC       (PubMed:6260203). In addition, possesses a phosphotransferase activity
CC       by which it can transfer a phosphate from a donor nucleoside
CC       monophosphate to an acceptor nucleoside, preferably inosine,
CC       deoxyinosine and guanosine (By similarity). Has the highest activities
CC       for IMP and GMP followed by dIMP, dGMP and XMP (PubMed:6260203). Could
CC       also catalyze the transfer of phosphates from pyrimidine monophosphates
CC       but with lower efficiency (By similarity). Through these activities
CC       regulates the purine nucleoside/nucleotide pools within the cell
CC       (PubMed:6260203). {ECO:0000250|UniProtKB:P49902,
CC       ECO:0000269|PubMed:6260203}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a ribonucleoside 5'-phosphate + H2O = a ribonucleoside +
CC         phosphate; Xref=Rhea:RHEA:12484, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:18254, ChEBI:CHEBI:43474, ChEBI:CHEBI:58043; EC=3.1.3.5;
CC         Evidence={ECO:0000269|PubMed:6260203};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12485;
CC         Evidence={ECO:0000305|PubMed:6260203};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2'-deoxyribonucleoside + a ribonucleoside 5'-phosphate = a
CC         2'-deoxyribonucleoside 5'-phosphate + a ribonucleoside;
CC         Xref=Rhea:RHEA:19961, ChEBI:CHEBI:18254, ChEBI:CHEBI:18274,
CC         ChEBI:CHEBI:58043, ChEBI:CHEBI:65317; EC=2.7.1.77;
CC         Evidence={ECO:0000250|UniProtKB:P49902};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + IMP = inosine + phosphate; Xref=Rhea:RHEA:27718,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:17596, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:58053; EC=3.1.3.99;
CC         Evidence={ECO:0000269|PubMed:6260203};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:27719;
CC         Evidence={ECO:0000305|PubMed:6260203};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GMP + H2O = guanosine + phosphate; Xref=Rhea:RHEA:27714,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:16750, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:58115; Evidence={ECO:0000269|PubMed:6260203};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:27715;
CC         Evidence={ECO:0000305|PubMed:6260203};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dIMP + H2O = 2'-deoxyinosine + phosphate;
CC         Xref=Rhea:RHEA:29383, ChEBI:CHEBI:15377, ChEBI:CHEBI:28997,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:61194;
CC         Evidence={ECO:0000269|PubMed:6260203};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:29384;
CC         Evidence={ECO:0000305|PubMed:6260203};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dGMP + H2O = 2'-deoxyguanosine + phosphate;
CC         Xref=Rhea:RHEA:29379, ChEBI:CHEBI:15377, ChEBI:CHEBI:17172,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:57673;
CC         Evidence={ECO:0000269|PubMed:6260203};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:29380;
CC         Evidence={ECO:0000305|PubMed:6260203};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + XMP = phosphate + xanthosine; Xref=Rhea:RHEA:28530,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:18107, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57464; Evidence={ECO:0000269|PubMed:6260203};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:28531;
CC         Evidence={ECO:0000305|PubMed:6260203};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GMP + inosine = guanosine + IMP; Xref=Rhea:RHEA:69584,
CC         ChEBI:CHEBI:16750, ChEBI:CHEBI:17596, ChEBI:CHEBI:58053,
CC         ChEBI:CHEBI:58115; Evidence={ECO:0000250|UniProtKB:P49902};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dGMP + inosine = 2'-deoxyguanosine + IMP;
CC         Xref=Rhea:RHEA:69580, ChEBI:CHEBI:17172, ChEBI:CHEBI:17596,
CC         ChEBI:CHEBI:57673, ChEBI:CHEBI:58053;
CC         Evidence={ECO:0000250|UniProtKB:P49902};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dIMP + inosine = 2'-deoxyinosine + IMP; Xref=Rhea:RHEA:69572,
CC         ChEBI:CHEBI:17596, ChEBI:CHEBI:28997, ChEBI:CHEBI:58053,
CC         ChEBI:CHEBI:61194; Evidence={ECO:0000250|UniProtKB:P49902};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=inosine + UMP = IMP + uridine; Xref=Rhea:RHEA:69588,
CC         ChEBI:CHEBI:16704, ChEBI:CHEBI:17596, ChEBI:CHEBI:57865,
CC         ChEBI:CHEBI:58053; Evidence={ECO:0000250|UniProtKB:P49902};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=CMP + inosine = cytidine + IMP; Xref=Rhea:RHEA:69592,
CC         ChEBI:CHEBI:17562, ChEBI:CHEBI:17596, ChEBI:CHEBI:58053,
CC         ChEBI:CHEBI:60377; Evidence={ECO:0000250|UniProtKB:P49902};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=AMP + inosine = adenosine + IMP; Xref=Rhea:RHEA:69596,
CC         ChEBI:CHEBI:16335, ChEBI:CHEBI:17596, ChEBI:CHEBI:58053,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:P49902};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:6260203};
CC       Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000250|UniProtKB:P49902};
CC   -!- ACTIVITY REGULATION: Allosterically activated by various compounds
CC       including ATP, 2,3-BPG/2,3-Bisphosphoglyceric acid and Ap4A/P1,P4-
CC       bis(5'-adenosyl) tetraphosphate (PubMed:6260203). Binding of an
CC       allosteric activator is a prerequisiste to magnesium and substrate
CC       binding (By similarity). Inhibited by inorganic phosphate
CC       (PubMed:6260203). {ECO:0000250|UniProtKB:P49902,
CC       ECO:0000269|PubMed:6260203}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.2 mM for IMP {ECO:0000269|PubMed:6260203};
CC         KM=0.7 mM for dIMP {ECO:0000269|PubMed:6260203};
CC         KM=0.7 mM for GMP {ECO:0000269|PubMed:6260203};
CC         KM=1.1 mM for dGMP {ECO:0000269|PubMed:6260203};
CC       pH dependence:
CC         Optimum pH is 6.5. {ECO:0000269|PubMed:6260203};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000250|UniProtKB:P49902}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:P49902}.
CC   -!- SIMILARITY: Belongs to the 5'(3')-deoxyribonucleotidase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC097752; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC105488; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_006223828.1; XM_006223766.3.
DR   RefSeq; XP_006223830.1; XM_006223768.3.
DR   RefSeq; XP_006231646.1; XM_006231584.3.
DR   RefSeq; XP_006231648.1; XM_006231586.3.
DR   AlphaFoldDB; D3ZMY7; -.
DR   SMR; D3ZMY7; -.
DR   IntAct; D3ZMY7; 1.
DR   STRING; 10116.ENSRNOP00000027351; -.
DR   PhosphoSitePlus; D3ZMY7; -.
DR   jPOST; D3ZMY7; -.
DR   PaxDb; 10116-ENSRNOP00000027351; -.
DR   PeptideAtlas; D3ZMY7; -.
DR   Ensembl; ENSRNOT00055005980; ENSRNOP00055004507; ENSRNOG00055003734.
DR   Ensembl; ENSRNOT00060052178; ENSRNOP00060043401; ENSRNOG00060029685.
DR   Ensembl; ENSRNOT00065053608; ENSRNOP00065044057; ENSRNOG00065030938.
DR   AGR; RGD:2323387; -.
DR   CTD; 22978; -.
DR   RGD; 2323387; Nt5c2.
DR   eggNOG; KOG2469; Eukaryota.
DR   HOGENOM; CLU_017845_3_0_1; -.
DR   InParanoid; D3ZMY7; -.
DR   OrthoDB; 3626840at2759; -.
DR   TreeFam; TF315266; -.
DR   Reactome; R-RNO-2161541; Abacavir metabolism.
DR   Reactome; R-RNO-74259; Purine catabolism.
DR   Reactome; R-RNO-9755088; Ribavirin ADME.
DR   PRO; PR:D3ZMY7; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000020179; Expressed in kidney and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0008253; F:5'-nucleotidase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0050484; F:GMP 5'-nucleotidase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0050483; F:IMP 5'-nucleotidase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0050146; F:nucleoside phosphotransferase activity; ISS:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; ISO:RGD.
DR   GO; GO:0046085; P:adenosine metabolic process; IDA:RGD.
DR   GO; GO:0000255; P:allantoin metabolic process; ISO:RGD.
DR   GO; GO:0043605; P:amide catabolic process; ISO:RGD.
DR   GO; GO:0046055; P:dGMP catabolic process; ISO:RGD.
DR   GO; GO:0046054; P:dGMP metabolic process; IDA:UniProtKB.
DR   GO; GO:0046038; P:GMP catabolic process; ISO:RGD.
DR   GO; GO:0006202; P:GMP catabolic process to guanine; ISO:RGD.
DR   GO; GO:0046037; P:GMP metabolic process; IDA:UniProtKB.
DR   GO; GO:0006204; P:IMP catabolic process; ISO:RGD.
DR   GO; GO:0046040; P:IMP metabolic process; IDA:UniProtKB.
DR   GO; GO:0050689; P:negative regulation of defense response to virus by host; ISO:RGD.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; ISO:RGD.
DR   CDD; cd07522; HAD_cN-II; 1.
DR   Gene3D; 3.40.50.1000; HAD superfamily/HAD-like; 2.
DR   InterPro; IPR036412; HAD-like_sf.
DR   InterPro; IPR008380; HAD-SF_hydro_IG_5-nucl.
DR   InterPro; IPR023214; HAD_sf.
DR   InterPro; IPR016695; Pur_nucleotidase.
DR   NCBIfam; TIGR02244; HAD-IG-Ncltidse; 1.
DR   PANTHER; PTHR12103; 5'-NUCLEOTIDASE DOMAIN-CONTAINING; 1.
DR   PANTHER; PTHR12103:SF17; CYTOSOLIC PURINE 5'-NUCLEOTIDASE; 1.
DR   Pfam; PF05761; 5_nucleotid; 1.
DR   PIRSF; PIRSF017434; Purine_5'-nucleotidase; 1.
DR   SUPFAM; SSF56784; HAD-like; 1.
PE   1: Evidence at protein level;
KW   Allosteric enzyme; ATP-binding; Cytoplasm; Hydrolase; Magnesium;
KW   Metal-binding; Nucleotide metabolism; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Transferase.
FT   CHAIN           1..560
FT                   /note="Cytosolic purine 5'-nucleotidase"
FT                   /id="PRO_0000455115"
FT   REGION          541..560
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          548..560
FT                   /note="Required for tetramer assembly"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   ACT_SITE        52
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PIRSR:PIRSR017434-1"
FT   ACT_SITE        54
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000255|PIRSR:PIRSR017434-1"
FT   BINDING         52
FT                   /ligand="IMP"
FT                   /ligand_id="ChEBI:CHEBI:58053"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         52
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000255|PIRSR:PIRSR017434-2"
FT   BINDING         54
FT                   /ligand="IMP"
FT                   /ligand_id="ChEBI:CHEBI:58053"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         54
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000255|PIRSR:PIRSR017434-2"
FT   BINDING         144
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         154
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         202
FT                   /ligand="IMP"
FT                   /ligand_id="ChEBI:CHEBI:58053"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         206
FT                   /ligand="IMP"
FT                   /ligand_id="ChEBI:CHEBI:58053"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         215
FT                   /ligand="IMP"
FT                   /ligand_id="ChEBI:CHEBI:58053"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         249
FT                   /ligand="IMP"
FT                   /ligand_id="ChEBI:CHEBI:58053"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         250
FT                   /ligand="IMP"
FT                   /ligand_id="ChEBI:CHEBI:58053"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         251
FT                   /ligand="IMP"
FT                   /ligand_id="ChEBI:CHEBI:58053"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         292
FT                   /ligand="IMP"
FT                   /ligand_id="ChEBI:CHEBI:58053"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         351
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000255|PIRSR:PIRSR017434-2"
FT   BINDING         453
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         456
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   MOD_RES         418
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   MOD_RES         502
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   MOD_RES         511
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   MOD_RES         527
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3V1L4"
SQ   SEQUENCE   560 AA;  64866 MW;  8BFA7579DE41B0C8 CRC64;
     MMTSWSDRLQ NAADVPANMD KHALKKYRRE AYHRVFVNRS LAMEKIKCFG FDMDYTLAVY
     KSPEYESLGF ELTVERLVSI GYPQELLNFA YDSTFPTRGL VFDTLYGNLL KVDAYGNLLV
     CAHGFNFIRG PETREQYPNK FIQRDDTERF YILNTLFNLP ETYLLACLVD FFTNCPRYTS
     CDTGFKDGDL FMSYRSMFQD VRDAVDWVHY KGSLKEKTVE NLEKYVVKDG KLPLLLSRMK
     EVGKVFLATN SDYKYTDKIM TYLFDFPHGP KPGSSHRPWQ SYFDLILVDA RKPLFFGEGT
     VLRQVDTKTG KLKIGTYTGP LQHGIVYSGG SSDTICDLLG AKGKDILYIG DHIFGDILKS
     KKRQGWRTFL VIPELAQELH VWTDKSSLFE ELQSLDIFLA ELYKHLDSSS NERPDISSIQ
     RRIKKVTHDM DMCYGMMGSL FRSGSRQTLF ASQVMRYADL YAASFINLLY YPFSYLFRAA
     HVLMPHESTV EHTHVDINEM ESPLATRNRT SVDFKDTDYK RHQLTRSISE IKPPNLFPLA
     PQEITHCHDE DDDEEEEEEE
//
